Immunic IMUX
NASDAQ IMUX
$7.43 -0.05 (-0.67%)
As of: Oct 22, 2026 · 12:29 PM EDT

Immunic (IMUX) Other Operating Expenses (2014 - 2022)

Updated

Immunic (IMUX) reported Other Operating Expenses of $32.97 million for Q4 2022.

Analysis

Immunic (IMUX) Other Operating Expenses (2014 - 2022) Analysis & Trends

Dating back to Q4 2014, Immunic's Other Operating Expenses record includes 8 quarters.

  • By year, Other Operating Expenses came in at $17.25 million in FY2021 and -$2.4 million in FY2018.
  • The Q4 2022 figure ranks as the highest quarterly Other Operating Expenses in data going back to Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,172.40 Bn 1,140.99 Bn 19.71 Bn
2 Johnson & Johnson 642.90 Bn 561.42 Bn 17.26 Bn
3 AbbVie 502.02 Bn 475.14 Bn 12.70 Bn
4 Merck 375.88 Bn 330.26 Bn 12.21 Bn
5 Novartis Ag 302.81 Bn 266.80 Bn 11.24 Bn
6 Astrazeneca 268.58 Bn 242.27 Bn 12.86 Bn
7 Amgen 242.38 Bn 197.78 Bn 7.24 Bn
8 Gilead Sciences 193.63 Bn 167.83 Bn 6.22 Bn
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn
10 Immunic 315.67 Mn -76.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 32.97 Mn
Mar 31, 2021 17.25 Mn
Mar 31, 2019 -6.37 Mn
Dec 31, 2018 -1,000.00
Sep 30, 2018 -2.40 Mn
Mar 31, 2018 -12.20 Mn
Dec 31, 2015 1,000.00
Dec 31, 2014 1,000.00
API Access

Immunic Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=IMUX&period=max&api_key=YOUR_API_KEY